&EPA
United States
Environmental Protection
Agency
         TECHNOLOGY EVALUATION REPORT
         Biological Inactivation Efficiency by HVAC
         In-Duct Ultraviolet Light Systems
         UftraViolet Devices, Inc.
         Aftru-VV-Flex
         Office of Research and Development
         National Homeland Security
         Research Center

-------
                                       EPA 600/R-06/049
                                          May 2006
Technology Evaluation Report

Biological Inactivation Efficiency
by HVAC In-Duct Ultraviolet Light
Systems

Ultraviolet Devices, Inc.
Altru-V V-Flex
             By

             Karin Foarde, Deborah Franke, Tricia Webber, James Hanley,
             and Kathleen Owen
             RTI International
             3040 Cornwallis Road
             Research Triangle Park, NC 27709

             Eric Koglin
             Task Order Project Officer
             National Homeland Security Research Center
             Office of Research and Development
             U.S. Environmental Protection Agency
             944 East Harmon Ave.
             Las Vegas, NV 89119

-------
                                          Notice

The U.S. Environmental Protection Agency (EPA), through its Office of Research and Development's
National Homeland Security Research Center (NHSRC), funded and managed this technology
evaluation through a Blanket Purchase Agreement (BPA) under General Services Administration
contract number GS23F0011L-3 with Battelle, with RTI under subcontract to Battelle. This report has
been peer and administratively reviewed and has been approved for publication as an EPA document.
Mention of trade names or commercial products does not constitute endorsement or recommendation for
use of a specific product.
                                             11

-------
                                          Foreword

The U.S. Environmental Protection Agency (EPA) is charged by Congress with protecting the nation's
air, water, and land resources. Under a mandate of national environmental laws, the Agency strives to
formulate and implement actions leading to a compatible balance between human activities and the
ability of natural systems to support and nurture life. To meet this mandate, the EPA's Office of
Research and Development (ORD) provides data and science support that can be used to solve
environmental problems and to build the scientific knowledge base needed to manage our ecological
resources wisely, to understand how pollutants affect our health, and to prevent or reduce environmental
risks.

In September 2002, EPA announced the formation of the National Homeland Security Research Center
(NHSRC). The NHSRC is  part of the Office of Research and Development; it manages, coordinates, and
supports a variety of research and technical assistance efforts. These efforts are designed to provide
appropriate, affordable, effective, and validated technologies and methods for addressing risks posed by
chemical, biological, and radiological terrorist attacks. Research focuses on enhancing our ability to
detect, contain, and clean up in the event of such attacks.

NHSRC's team of world renowned scientists and engineers is dedicated to understanding the terrorist
threat, communicating the risks, and mitigating the results of attacks. Guided by the roadmap set forth in
EPA's Strategic Plan for Homeland Security, NHSRC ensures rapid production and distribution of
security-related products.

The NHSRC has created the Technology Testing and Evaluation Program (TTEP) in an effort to provide
reliable  information regarding the performance of homeland security related technologies. TTEP
provides independent,  quality assured performance information that is useful to decision makers in
purchasing or applying the tested technologies. It provides potential users with unbiased, third-party
information that can supplement vendor-provided information. Stakeholder involvement ensures that
user  needs and perspectives are incorporated into the test design so that useful performance information
is produced for each of the tested technologies. The technology  categories of interest include detection
and monitoring, water treatment, air purification,  decontamination, and computer modeling tools for use
by those responsible for protecting buildings, drinking water supplies and infrastructure, and for
decontaminating structures and the outdoor environment.

The evaluation reported  herein was conducted by RTI International under contract to Battelle as part of
the TTEP program. Information on NHSRC and TTEP can be found at
http ://www. epa. gov/ordnhsrc/index. htm.
                                              in

-------
                                    Acknowledgments

The authors wish to acknowledge the support of all those who helped plan and conduct the evaluation,
analyze the data, and prepare this report. We would like to thank Dr. Leslie E. Sparks, USEPA, and Dr.
W. Gene Tucker, James Madison University, for their reviews of this report. We also acknowledge the
assistance and participation of our stakeholder group for their input to the test plan.
                                             IV

-------
                                         Contents

Notice	ii

Foreword	iii

Acknowledgments	iv

Abbreviations/Acronyms	vii

Executive Summary	ix

1.0 Introduction	 1

2.0 Technology Description	3

3.0 Test Procedures	5
       3.1  Operation of the Test Duct	5
       3.2  Preparation and Generation of Bioaerosol Challenges	6
       3.3  Sampling the Bioaerosols	7
       3.4  Bioaerosol Control Efficiency Calculation	7
       3.5  Average Dose of UV Delivered by the Device	8

4.0 Quality Assurance/Quality Control	9
       4.1 Equipment Calibration	9
          4.1.1  Reference Methods	9
           4.1.2  Instrument Checks	9
       4.2 Audits	9
           4.2.1  Performance Evaluation Audit	9
           4.2.2  Technical  Systems Audit	9
           4.2.3  Data Quality Audit	10
       4.3 QA/QC Reporting	10

5.0 Test Results	12

6.0 Performance Summary	13

7.0 References	14
                                              v

-------
                                            Figures




Figure 2-1. Device installed inside the test rig	4




Figure 2-2. Alternate view of device installed inside the test rig	4




Figure 3-1. Schematic of Test Duct	5









                                            Tables




Table 2-1.   Specifications of the Altru-V V-Flex	3




Table 4-1.   DQOs for Biological Aerosols	10




Table 5-1.   Inactivation Efficiency	12




Table 5-2.   Other Information for the Altru-V V-Flex	12
                                               VI

-------
                                Abbreviations/Acronyms
A
ANSI
ARTI
ASHRAE
ASME
ATCC
B
BG
BWA
°C
cfm
CPU
cm
CV
DQO
EPA
°F
fpm
ft
HVAC
in.
J
KC1
m
mL
NEMA
nm
NHSRC
QA
QC
OPC
ORD
Pa
PE
PFU
ampere
American National Standards Institute
Air-Conditioning and Refrigeration Technical Institute
American Society of Heating, Refrigerating and Air-Conditioning Engineers
American Society of Mechanical Engineers
American Type Culture Collection
Bacillus
Bacillus atrophaeus (formerly B. subtilis var. niger and Bacillus globigii)
biological warfare agent
degrees Celsius
cubic feet per minute
colony forming unit(s)
centimeter(s)
coeffi ci ent of vari ati on
data quality objective
U.S. Environmental Protection Agency
degrees Fahrenheit
feet per minute
feet
heating, ventilation and air-conditioning
inch(es)
joule
potassium chloride
meter(s)
milliliter(s)
micrometer(s)
microwatts(s)
National Electrical Manufacturers Association
nanometer(s)
National Homeland Security Research Center (EPA)
quality assurance
quality control
optical particle counter
Office of Research and Development (EPA)
pascal(s)
performance evaluation
plaque forming unit(s)
                                            vn

-------
psig               pounds per square inch gauge
QMP              quality management plan
QSA              quality system assessment
RMS              root mean square
RTI               Research Triangle Institute (RTI International)
S                  Serratia
sec                second(s)
TSA              technical system assessment
TTEP              Technology Testing and Evaluation Program
UV                Ultraviolet; the C band is used for disinfection
V                  volt(s)
W                 watt(s)
                                            Vlll

-------
                                    Executive Summary

The U.S. Environmental Protection Agency's (EPA's) National Homeland Security Research Center
(NHSRC) Technology Testing and Evaluation Program (TTEP) is helping to protect human health and
the environment from adverse impacts resulting from  acts of terror by carrying out performance tests on
homeland security technologies. Under TTEP, RTI recently evaluated the performance of the
Ultraviolet Devices, Inc. Altru-V V-Flex. The objective of testing the device was to evaluate its
bioaerosol inactivation efficiency as a heating, ventilation and air-conditioning (HVAC) in-duct
ultraviolet light system.

The product was tested using a test plan approved by EPA, Test/QA Plan for Biological Inactivation
Efficiency by HVAC In-Duct Ultraviolet Light Air Cleaners^ The tests were conducted  using three
organisms, two bacteria {Bacillus atrophaeus and Serratia marcescens) and one bacterial virus (MS2).
These organisms were selected because their sizes,  shapes and susceptibility toUV inactivation make
them reasonable surrogates for biological warfare agents (BWAs). Generally,  vegetative bacteria are
readily killed and bacterial spores are more difficult. To model use in an HVAC system,  RTI used a test
duct designed for testing filtration and inactivation efficiencies of aerosol, bioaerosol and chemical
challenges.

The bioaerosol inactivation efficiencies calculated for the three organisms were 71% for B. atrophaeus,
>99.98% for S. marcescens and 98% for MS2. The irradiance was measured as 1,940 |iW/cm2 at 145 cm
(57 in.) upstream from the closest lamp with an airflow of 0.93 m3/sec (1970 cfm). The system had
twelve lamps that were burned in for 100 hours prior to measurements.
                                              IX

-------
                                      1.0  Introduction

The U.S. Environmental Protection Agency's (EPA's) National Homeland Security Research Center
(NHSRC) is helping to protect human health and the environment from adverse impacts resulting from
intentional acts of terror. With an emphasis on decontamination and consequence management, water
infrastructure protection, and threat and consequence assessment, NHRSC is working to develop tools
and information that will help detect the intentional introduction of chemical or biological contaminants
in buildings or water systems, the containment of these contaminants, the decontamination of buildings
and/or water systems, and the disposal of material resulting from cleanups.

NHSRC's Technology Testing and Evaluation Program (TTEP) works in partnership with recognized
testing organizations; with stakeholder groups consisting of buyers, vendor organizations, and
permitters; and with the full participation of individual technology developers in carrying out
performance tests on homeland security technologies. The program evaluates the performance of
innovative homeland security technologies by developing test plans that are responsive to the needs of
stakeholders, conducting tests, collecting and analyzing data, and preparing peer-reviewed reports. All
evaluations are conducted in accordance with rigorous quality assurance (QA) protocols to ensure that
data of known and high quality are generated and that the results are defensible. TTEP provides high-
quality information that is useful to decision makers in purchasing or applying the tested technologies. It
provides potential users with unbiased, third-party information that can supplement vendor-provided
information. Stakeholder involvement ensures that user needs and perspectives are incorporated into the
test design so that useful performance information is produced for each of the tested technologies.

UV lamps have been used to inactivate airborne microorganisms for many years.
Much of the early work was directed at the control of very infectious microorganisms (particularly
Mycobacterium tuberculosis, the causative agent of tuberculosis), often in medical facilities.
Wavelengths within the short wave, or C band of UV light (UVC), were found to be the most effective
germicidal light wavelengths. UVC usually is generated by use of UVC fluorescent lamps.  These lamps
use electrical discharge through low-pressure mercury vapor enclosed in a glass tube that transmits UVC
light (primarily at the mercury wavelength of 253.7 nm). Because this wavelength has been found to be
about the optimum for killing microorganisms, UVC from mercury lamps also is referred to as UVG to
indicate that it is germicidal. UVG has been shown to inactivate viruses, mycoplasma, bacteria, and
fungi when used appropriately.

Numerous past studies of UVC to inactivate microorganisms have been conducted for a variety of
purposes and with a variety of methods.  No standard method  exists for evaluating culturable bioaerosol
inactivation by these devices. However, as part of the project entitled, "Defining the Effectiveness of
UV Lamps Installed in Circulating Air Ductwork" funded by the Air-Conditioning and Refrigeration
Technology Institute (ARTI), RTI developed a test method for measuring culturable bioaerosol
inactivation efficiencies by UV lights.(2) This method was derived from earlier bioaerosol air cleaner
test methods developed for determining the bioaerosol filtration efficiencies of various air cleaning
devices including room air cleaners and duct-mounted ventilation filters.(3'4'5) These bioaerosol methods
were based on RTFs extensive experience in the development of parti culate testing methods of various
air-cleaning devices.

-------
The current TTEP effort focuses on UV systems that are mounted in the HVAC ducting (in-duct UV
light systems) and that operate on a "fly-through" basis. That is, they are designed to destroy
bioaerosols in the flowing air stream as it passes through the device. This is distinguished from UV
devices that are designed to treat specific surfaces within the HVAC system, in particular, the cooling
coils and the condensate drain pan, to prevent biological growth on those surfaces.  This program tested
inactivation of airborne bioaerosols; inactivation of microorganisms on surfaces was not evaluated.

The bioaerosol tests were conducted using three organisms, consisting of two bacteria (spore-forming
Bacillus atrophaeus and the vegetative bacterium Serratia marcescens) and one bacterial virus (MS2)
that cover the range of potential interest for biological warfare agent (BWA) applications. These
organisms were selected because their sizes, shapes and susceptibility toUV inactivation make them
reasonable surrogates for BWAs.  Generally, vegetative bacteria are readily killed and bacterial spores
are more difficult. The spore form of the bacteria^ac/'/te atrophaeus (formerly B. subtilis var. niger
and Bacillus globigii or BG) was used as the surrogate for gram-positive spore-forming bacteria.  The
BG spore is elliptically shaped with dimensions of 0.7 to 0.8 by 1 to 1.5 jim. Serratia marcescens was
used as the surrogate for rod-shaped gram-negative bacteria. S. marcescens is 0.5 to 0.8 by 0.9 to 2.0
The bacterial virus (b acted ophage) MS2, having approximately the same aerosol characteristics as a
human virus, was used as a surrogate for the viruses of similar and larger size and shape. Although the
individual virus particles are in the 0.02 - 0.03 jim size range, the test particle size for the virus tests
spanned a range of sizes (poly dispersed bioaerosol) in the micron range. This test was not designed to
study the inactivation efficiencies for individual virus singlets; rather, it was designed to determine the
inactivation efficiencies for virus particles as they are commonly found indoors.  A representative
challenge would be a polydispersed aerosol containing the bacteriophage because:
$   The aerosols created from sneezing and coughing vary in size from < 1 to 20 |im, but the largest
    particles settle out and only the smaller sizes remain in the air for extended periods for potential
    removal by an air cleaner; (6)
$   For some viruses (e.g., Coxsackie virus), few viruses have been found associated with the smallest
    particles; (7) and
$   Nearly all  1 - 2 jim particles  are deposited in the respiratory tract, while larger particles may not be
    respired.

-------
                                2.0  Technology Description

The information in this section was provided by the vendor and was not evaluated by RTI.

The Ultraviolet Devices, Inc.'s Altru-V V-Flex system is designed to fit into any air handling or duct
system. The support column allows mounting of UV lamps on all four sides and up and down its height,
allowing for 360° irradiation that delivers the most UVC energy per unit area. The lamps can be
installed vertically or horizontally, with multiple high-power, single-ended biaxial lamps mounted to a
single support column as close as 9-inch centers. The configuration tested contained 12 lamps. The
lamps are type TUV PL-L60W, part number D07-1303-51. There were 3 lamp units.

Table 2-1 provides information on the system as supplied by the vendor. Figures 2-1 and 2-2 provide
views of the device as tested, installed in accordance with the manufacturer's specifications. The ballasts
are not shown in a separate picture as each of the twelve lamp modules contained one ballast. All were
contained within the test rig.

Table 2-1. Specifications of the Altru-V V-Flex
Attribute
Total power for the lamp (watts)
Total UVC power for the lamp (watts)
Irradiance (output) of the lamp, give
distance and other information (e.g.,
airflow) (W/cm2)
Dosage (J/cm2 or W-s/cm2)
Ballast root mean square (RMS)
voltage and current
Dimensions of the lamp
Dimensions of the ballast box
Configuration
Other lamp characteristics
Specification
720 total watts, 60 watts per lamp module
12 lamp modules used in this particular installation
21 6 total UVC W, 18 Wfor each lamp
See note a. Range approximately 166 to 250 uW per square cm at 1 meter
See note b
To Lamp: 118 VAC, 0.67 Amp
Ballast Input: 120 VAC, 0.67 Amp
The lamps are 38.5 cm (15.2 in.) long, 41.5 cm (16.3 in.) with base
The ballasts are part of each of the 12 lamp modules
12 lamp modules (each module consisting of a ballast and bulb) were deployed in 3
units. The front unit was positioned vertically in the center of the duct and consisted
of 8 lamp modules configured such that 2 bulbs were deployed horizontally in each of
4 different heights in the duct. The lamps were placed so that the 4 heights of lamps
were not in one column. Two back units, each consisting of 2 lamp modules, were
positioned vertically against the side of the duct, so that when paired together they
were arranged such that 2 bulbs were horizontally deployed at 2 different heights in
the duct.
Reflective material was supplied by the vendor and used inside the duct according to
vendor specifications.
a.   UVDI finds this measurement of very little relative value in actual performance of HVAC applications. It varies
    depending upon the test fixture and sensor used. It also varies greatly by the geometry of the test fixture
    enclosure. UDVI feels it is not an appropriate way to indicate what energy is applied in an HVAC system with
    different geometry, reflectivity and in a moving air stream of a particular temperature.  None of this is reflected
    in a single 1-meter irradiance measurement of dubious accuracy. UDVI prefers to use a mathematical model
    taking into account the system variables and the UV output of each lamp adjusted for the variables.  The
    number given here is for reference only and can vary.

-------
b.   UVDI uses a very sophisticated model to estimate the dosage delivered in a particular system. The model is
    based upon the system geometry and all the variables affecting lamp output. The model basis includes:
       The reflective material supplied by the vendor and installed as per their sketch
       Air flow velocity (and therefore air flow volume-CFM)
       Air temperature.
   Figure 2-1.  Device installed inside the
   test rig. Front unit shown through door of
   test rig.

For more information on the Altru-V V-Flex, contact:

Dave Witham (VP Technology)
Ultraviolet Devices, Inc.
26145  Technology Drive
Valencia, CA 91355
Phone: 661-295-8140, extension 667
Fax: 661-295-8350
davew@uvdi. com
www.altruv.com
Figure 2-2. Alternate view of device
installed inside the test rig.  Front unit, 2
back units, and reflective material shown.

-------
                                      3.0  Test Procedures
  3.1 Operation of the Test Duct
  The testing was conducted in the test duct shown schematically in Figure 3-1.  The test section of the
  duct is 0.61 m by 0.61 m (24 in. by 24 in.). The locations of the major components, including the
  sampling probes, the device section (where the UV device is installed), and the aerosol generator (site of
  bioaerosol injection) are shown. A light baffle was inserted into the rig between the biological samplers
  and the device section to block the UVC from inactivating the upstream challenge prior to collection
  when the irradiance at the upstream probes is calculated to exceed 900 uW/cm2. The baffle is located 18
  inches downstream of the upstream probes. A traverse of the air velocities across the baffle was
  performed to ensure uniformity of air flow. The test duct is operated following procedures in the
  ANSI/ASHRAE (American National Standards Institute/ American Society of Heating, Refrigerating
  and Air-Conditioning Engineers) Standard 52.2-1999, Method of Testing General Ventilation Air-
  Cleaning Devices for Removal Efficiency by Particle Size. (8)
                Exhaust
                  to
                 Room
       Outlet Filter Bank
                        ASME
                        N°zle
Room
Air
A
H
C>-+--q






x
(")
                  \.
                          |
  Biological
  Sampling
                 Downstream Mixer
\
Blower
Inlet Filter
  Bank
                                                            Device
                                                            Section
          Flow Control
             Valve
          Aerosol
         Generator
Biological
Sampling
                   Backup
                     Filter
                    Holder
                 (Used When
                 Dust-loading)
  Figure 3-1.  Schematic of Test Duct. UV system is placed in device section.
  While Figure 3-1 shows the test duct without recirculation, during testing, the duct may be operated with
  or without recirculation. The decision for recirculation mode is based on building HVAC considerations.
  Because of the HEPA filters at the beginning and the end of the duct, the recirculation mode does not
  affect the test data as long as all other criteria are met.

  The air flow rate through the duct during this testing was 0.93 mVsec (1970 cfm). This flow creates a
  typical air velocity (492 fpm) in the duct, and has been used extensively in prior testing of air cleaning
  devices in this rig. The air temperature entering the device was approximately 23 °C.  Air flow rate and
  temperature can have an impact on lamp performance, and the values used in this testing are consistent
  with vendor specifications. As  explained in the VanOsdell and Foarde report, (2) lamps are designed for
  an optimal temperature, and either higher or lower values may lower the irradiance.

  Prior to testing the device, the UV lamps were operated for a standard 100-hr "burn-in" period.

                                                 5

-------
In a given run, one of the three challenge bioaerosols - prepared as described in Section 3.2 - was
injected upstream of the device.  A no-light test was performed with the UV lights turned off, to
determine the microorganism loss that would occur simply as the result of deposition in the test duct,
and as the result of kill caused by the physical rigors of flowing through the device. See Section 4.3 for
the acceptable range of the penetration for this test. As discussed later, the performance of the device
was then reported as the device's efficiency in inactivating the organism with the light on, corrected to
account for the loss of organisms observed in the absence of UV light.

In addition to the measurement of the concentration of culturable organisms upstream and downstream
of the device, other measurements that were made include:

•  The energy required to operate the unit, including the direct total power consumption by the lamp
   and ballast, the pressure drop across the device (impacting air handler requirements), and the
   temperature rise through the unit, if any (impacting cooling coil energy consumption).

•  A single measurement of the intensity of 254 nm UV radiation (|iW/cm2) at a point 145 cm (57 in.)
   upstream from the closest lamp, to demonstrate that the lamps were functioning and to provide a test
   reference value for the laboratory for documentation purposes.

3.2  Preparation and Generation of Bioaerosol Challenges
The bioaerosol tests were conducted using three organisms, two bacteria (Bacillus atrophaeus and
Serratia marcescens) and one bacterial virus (MS2). The selection of the bioaerosols was discussed in
Section 1.

The microbial challenge suspensions were  prepared by inoculating the test organism onto solid or into
liquid media, incubating the culture until mature, wiping organisms from the surface of the pure culture
(if solid media), and eluting them into sterile fluid to a known concentration to  serve as a stock solution.
The organism preparation was then diluted into sterile nebulizing fluid. The nebulizing fluid was
composed of salts (buffering), peptone and antifoam (S. marcescens only).  The composition of the
nebulizing fluid should have provided a protective effect similar to organic matter (dirt, debris, etc.) for
the S. marcescens and possibly the MS2 against the inactivation of the UVC. Based on the  ARTI study,
little or no effect was anticipated for the B. atrophaeus as spores were found to be relatively unaffected
by protective factors.(2) The nebulizing fluid was quantified on trypticase soy agar to enumerate the
bacteria.

The bacteriophage challenge was prepared by inoculating a logarithmic phase broth culture of the host
bacteria (E. coif) with bacteriophage and allowing it to multiply overnight or until the majority of the
host bacteria were lysed (ruptured or broken down). The mixture was processed to collect and
concentrate the bacteriophage. Then, the phage stock was filter sterilized (0.2 jim) to remove the
bacteria. The bacteriophage stock was used as the challenge aerosol.  The concentration of the
bacteriophage stock was approximately 1 x 109 or higher plaque forming units (PFU)/mL. The virus
assay used a standard double agar layer plaque assay, in which host cell Escherichia coli C3000 (ATCC
15597) in the log phase of growth and serial dilutions of the MS2 virus stock (ATCC 15597-B1) were
combined and top agar added and then poured onto bottom agar plates.(9)  After incubation,  at least
overnight, at 37 °C, plaques  (loci of infection) were counted against an opaque  lawn of host cell E. coli
C3000.

-------
The challenge organism suspensions were aerosolized using a Collison nebulizer (BGI, Waltham, MA)
at 15 psi air pressure.  The Collison nebulizer generated droplets with an approximate volume mean
diameter of 2 jim. The particle diameter after the water evaporated depended on the solids content of
the suspension and the size of the suspended particles. Prior experience has shown that the bacterial
organism aerosols generated by this procedure are primarily singlets.

3.3 Sampling the Bioaerosols
All the bioaerosols were collected in liquid impingers, AGI-4 (Ace Glass Inc., Vineland, NJ). Because
exposure to UV radiation is a common environmental hazard,  cells have developed a number of repair
mechanisms to counteract UV-induced damage that must be considered when experimentally measuring
UV effects. Collecting in  impinger fluid maximized the collection of damaged organisms. After
sampling, the impinger fluid was plated and incubated at appropriate times and temperatures for the test
organism being used.  To quantify the microbial counts, the plates were incubated at the appropriate
temperature and time for the test organism (overnight to a week). Colonies or plaques were counted.

3.4 Bioaerosol Control Efficiency Calculation
The efficiency of the device for inactivating airborne bioaerosols was then calculated as:

Airborne Inactivation Efficiency (%) = 100 (1 - Survival Ratecorrected)                       (Equation  1)

The calculation of the test organism survival rate (culturable transmission) was based on the ratio of the
downstream to upstream culturable organism counts.  To remove system bias, the Survival Rate was
corrected by the results of the blank no-light transmission test.  The blank no-light transmission rate
(light was not turned on in the test duct) was calculated the same as the survival rate test, but using the
culturable organism counts from the no-light tests.
3.5 Average Dose of UV Delivered by the Device
The equation used to describe the effect of UV on a single species population of airborne
microorganisms is:

                     Nt/No = exp(- k • dose)                                        (Equation 2)

where:
        Nt =  the number of microorganisms at time t,
        No =  the number of microorganisms at the start,
         k =  a microorganism-dependent rate constant, in cm2/|iW-s.


The fractional  inactivation achieved by the device is (1-Nt/No), as indicated in Equation 1.

We calculated  the dose by rearranging Equation 2 to yield

                           Dose = ln(1~Nt/No)                              (Equation 3)

-------
Mean dose was computed from Equation 3 using the values of Nt and No obtained with B. atrophaeus
and using the organism-specific value of k for this organism (1.6 x 10"4 V 0.3x 10"4 cm2/|iW-s). B.
atrophaeus was selected for determining dose based on earlier RTI measurements as discussed in
Amendment 1 of the test plan.

The UV dose calculated in this manner is the mean dose to a single organism having an "average"
trajectory through the device.  It is reported here as a characteristic of the device being tested. Dose is
shown as a mean and a range plus standard deviation, reflecting the natural variation in a population of
microorganisms.

-------
                         4.0  Quality Assurance/Quality Control

Quality assurance/quality control (QA/QC) procedures were performed in accordance with the program
QMP and the test/QA plan for this evaluation.(10'1}

4.1 Equipment Calibration

4.1.1 Reference Methods

As noted in Chapter 1, while reference methods were not available for determining the inactivation
efficiency of the device, accepted methods developed and used in related work were used. Test
specifications given in the appendices of the approved test/QA plan were derived from the related
ASHRAE 52.2 method, with additional specifications and quality control checks relevant to this
testing.(1'8)

4.1.2 Instrument Checks

The Altru-V V-Flex was installed in the test duct, and operated and maintained according to the
vendor's instructions throughout the test. No maintenance was required during the test.

4.2 Audits

4.2.1 Performance Evaluation Audit

No PE audits were performed during this test.

4.2.2  Technical Systems Audit

The RTI Quality Manager conducted a combined QSA/TSA to ensure that the technology evaluation
was performed in accordance with the approved test/QA plan and the TTEP QMP. (1'10) Using a prepared
checklist reflecting the test/QA plan, the RTI Quality Manager reviewed task systems as well  as
technology-specific sampling and analysis methods used, compared actual test procedures with those
specified in the test/QA plan, and reviewed data acquisition and handling procedures.(1) Observations
from this audit were documented and submitted to the RTI Task Manager. No significant findings were
noted in this assessment that might impact the quality of the evaluation results. The records concerning
the TSA are permanently stored with the RTI Task Manager.

The EPA Quality Manager conducted a combined QSA/TSA to independently assess conformance to
the approved test/QA plan of project activities.(1) No significant findings were noted in this assessment
that might impact the quality of the evaluation results. Minor recommendations were made and are
being implemented.

4.2.3 Data Quality Audit

At least 10% of the data acquired during the evaluation was audited by the RTI Quality Manager  who
traced the data from the initial acquisition, through reduction and statistical analysis, to final reporting,

-------
to ensure the integrity of the reported results. All calculations performed on the data undergoing the
audit were checked. This activity is summarized in a technology-specific report to the RTI Task
Manager.

4.3 QA/QC Reporting

Each assessment and audit was documented in accordance with the test/QA plan.(1) Once the assessment
report was prepared, the RTI Task Manager ensured that a response was provided as appropriate. For
this technology evaluation, no significant findings were noted in any assessment or audit, and no follow-
up corrective action was necessary.

The testing followed quality assurance and quality control requirements as given in the test/QA plan.
The RTI Quality Assurance Manager reviewed the test results and the quality control data and
concluded that the data quality objectives as shown in Table 4-1 and in Amendment 1 of the test/QA
plan were attained.

Table 4-1.  DQOs for Biological Aerosols
Parameter
Minimum upstream
counts for samplers
Maximum counts for
samplers
1 00% Penetration
(no light)
(correlation test)
Upstream CPUs
Upstream PFUs
Frequency and
description
Each efficiency test.
Each efficiency test.
Performed at least once
per test sequence per
organism.
Each test. Statistical check
of data quality.
Each test. Statistical check
of data quality.
Control Limits
Minimum of 10
CFUa/plate or PFUb/plate
Maximum of 500 CFU/plate or 800 PFUb/plate
Test
Oraanism
B. atrophaeus
S. marcescens
MS2
Acceptable
Penetration Range
0.85 to 1.1 5
0.80 to 1.20
0.75 to 1.25
CVC # 0.25
CVC # 0.35
 CFU =  colony forming units
b PFU =  plaque forming unit
c CV  =  coefficient of variance

Data quality objectives (DQOs) are qualitative and quantitative statements designed to ensure that the
type, quality, and quantity of data used are appropriate for the intended application. In addition, the
minimum and maximum upstream counts help to ensure that the challenge concentration of each
organism entering the UV device remains at an acceptably steady value that is sufficiently low such that
device performance should be independent of the concentration at the test conditions used in this study.
                                               10

-------
                                       5.0 Test Results
The bioaerosol inactivation efficiency results, derived using Equation 1, are given in Table 5-1. Table 5-
2 provides other information about the UV system.

Table 5-1. Inactivation Efficiency

Inactivation efficiency,
(UV light on) %
Test organism
Spore form of bacteria
(B. atrophaeus)
71
Vegetative bacteria
(S. marcescens)
> 99.98a
Bacterial virus
(MS2 phage)
98
a - the value 99.98 represents a 95% confidence limit for S. marcescens. There were no downstream counts
measured.
Table 5-2. Other Information for the Altru-V V-Flex
Attribute
Test duct operating conditions
Air flow rate
Inlet and outlet temperature
UV exposure conditions provided by device
Mean dosage calculated from Equation 3 and range
resulting from standard deviation of the k value
A single irradiance measurement at 254 nm
Measures of energy consumption by the unit
Power consumed by the lamps/ballasts and by any
ancillary equipment required by the vendor
Pressure drop across the device
Air temperature rise through the device
Measured or Calculated Values

0.93 m3/sec(1 970 cfm)
Upstream 23.2 °Ca (73.8°F) , Downstream
°Ca (75.4 °F)
24.1

7,651 (6,443 - 9,416) uW-s/cm2
1 ,940 uW/cm2 at 145 cm (57 in.) upstream
the closest lamp at 0.93 m3/sec (1 970 cfm)
from

755 W
9.5 Pa (0.038 in.H20)
0.9°Ca(1.6°F)
a - the accuracy of the thermometers are V0.5 °C.
                                               11

-------
                                6.0 Performance Summary

This verification report addresses the inactivation efficiency performance (Table 5-1) for the Ultraviolet
Devices, Inc. Altru-V V-Flex UV light system that operates in an HVAC system. Other measures are
given in Table 5-2. Users may wish to consider other performance parameters such as service life and
cost when selecting a UV light system for their application.

The bioaerosol inactivation efficiencies calculated for the three organisms were 71% for B. atrophaeus,
> 99.98% for S. marcescens and 98% for MS2. The irradiance was measured as 1,940 |iW/cm2 at 145
cm (57 in.) upstream from the closest lamp with an airflow of 0.93 m3/sec (1970 cfm). The system had
twelve lamps that were burned in for 100 hours prior to measurements. The spore form of the bacteria 5.
atrophaeus is more resistant to being killed by UV than the vegetative bacteria S. marcescens.
                                              12

-------
                                      7.0  References
1.  RTI. 2005. Test/QA Plan for Biological Inactivation Efficiency by HVAC In-Duct Ultraviolet Light
   Air Cleaners. Research Triangle Institute, Research Triangle Park, NC.

2.  VanOsdell, D. and K. Foarde. 2002. Final Report ARTI-21CR/610-40030-01 Project -Defining the
   Effectiveness of UV Lamps Installed in Circulating Air Ductwork, Air-Conditioning and
   Refrigeration Technology Institute, 4100 N. Fairfax Drive, Suite 200, Arlington, Virginia 22203.
   http ://www. arti-21 cr. org/research/completed/fmalreports/4003 0-fmal .pdf

3.  Foarde, K. and J. Hanley. 2001. Determine the Efficacy of Antimicrobial Treatments of Fibrous Air
   Filters. ASHRAE Transactions. Volume 107, Part 1. 156-170.

4.  Foarde, K.K. and J.T. Hanley. 1999.  A New Laboratory Method for Measuring the Bioaerosol
   Filtration Efficiency of Air Cleaners. Proceedings: 1999 Air Filtration Conference: Fall Topical
   Conference pp. 47-54.

5.  Foarde, K.K., J.T. Hanley, D.S. Ensor,  andP.F. Roessler. 1999. Development of a Method for
   Measuring Single-Pass Bioaerosol Removal Efficiencies of a Room Air Cleaner. Aerosol Science
   and Technology. 30: 223-234.

6.  Knight, V 1973. Viral and Mycoplasmal Infections of the Respiratory Tract, Lea &  Febiger,
   Philadelphia, PA.

7.  Buckland, F.E., and Tyrell, D.A.S. 1962. Loss of Infectivity on Drying Various Viruses, Nature
   195: 1063-1064.

8.  ANSI/ASHRAE (American National Standards Institute/American Society of Heating, Refrigerating
   and Air-Conditioning Engineers). 1999. ANSI/ASHRAE  Standard 52.2-1999, Method of Testing
   General Ventilation Air-Cleaning Devices for Removal Efficiency by Particle Size, Section 5.16.2,
   Atlanta, GA.

9.  Adams, M.G. (1959).  Bacteriophages. Interscience, New York.

10. Battelle. Quality Management Plan (QMP) for the Technology Testing and Evaluation Program
   (TTEP), Version 1, January  2005. Columbus, OH.
                                              13

-------